Is Immediate Surgery Always Necessary for CIN2 Lesions?

Cervical intraepithelial neoplasia grade 2 (CIN2) represents a challenging clinical scenario in modern gynecology. Specifically, clinicians must balance treatment benefits and reproductive harms. This challenging balance makes cervical precancer management highly controversial. Fortunately, a new target trial emulation study offers critical clarity on this clinical dilemma. Consequently, physicians can now make better-informed choices regarding treatment timing.

Redefining Cervical Precancer Management Strategies

The study showed that immediate treatment correlated with a high rate of potentially unnecessary tissue excision. Specifically, 36.2% of immediate-treatment patients had less severe lesions than CIN2 on final pathology. In contrast, only 7.8% of the delayed-treatment cohort experienced unnecessary excision. Thus, delaying treatment for at least six months significantly reduces the burden of over-treatment. Moreover, preserving healthy cervical tissue remains crucial for women of reproductive age. Therefore, this research supports a more conservative approach in low-risk individuals. Nevertheless, providers must carefully monitor patients during this observational period.

Understanding the Potential Risks of Delay

Some clinicians worry that delayed intervention could let the disease progress to cancer. However, the trial demonstrated that three-year risks for severe abnormalities remained remarkably similar. Specifically, the three-year risk for CIN grade 3 or worse was 8.85% for immediate excision. Conversely, the risk reached 10.31% for the delayed treatment cohort. Furthermore, invasive cancer was exceptionally rare in both groups at under 0.5%. Consequently, delaying treatment does not compromise safety over a three-year window. Instead, it allows many low-risk lesions to regress naturally without intervention.

Frequently Asked Questions

Q1: What is the main clinical takeaway of the target trial emulation on CIN2?

The study demonstrates that delaying treatment for cervical intraepithelial neoplasia grade 2 (CIN2) by at least six months does not increase the three-year risk of cervical cancer. Additionally, a delayed approach avoids many potentially unnecessary tissue excisions.

Q2: Why is avoiding immediate surgical excision beneficial for patients?

Avoiding immediate surgical excision helps protect healthy cervical tissue. Consequently, this conservative strategy reduces obstetric risks like preterm birth and cervical incompetence, which are major concerns for young patients.

Q3: Does active surveillance compromise safety over a three-year period?

No, the study showed that the risk of invasive cervical cancer and severe progression was extremely low and nearly identical in both the immediate and delayed groups. However, patients must receive consistent monitoring during surveillance.

References

1. Cheung LC et al. Benefits and Harms of Immediate Versus Delayed Treatment of Cervical Intraepithelial Neoplasia Grade 2 : A Target Trial Emulation. Ann Intern Med. 2026 Jun 23. doi: 10.7326/ANNALS-25-04053. PMID: 42330497.
2. Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020;24(2):102-131. doi: 10.1097/LGT.0000000000000525.
3. Cheung LC, Egemen D, et al. Enduring consensus guidelines for cervical cancer screening and management: introduction to the scope and process. J Low Genit Tract Dis. 2024;28(2):117–23. doi: 10.1097/LGT.0000000000000530.